Phase 3 data show Deuruxolitinib significantly improve scalp hair regrowth in Alopecia Areata
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
He is Proficient in overseeing and leading teams for running successful business operations
The objective of launching these products at AAHAR is to create awareness on the consumption of protein based products
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore
Mindset disagrees with and denies the allegations set forth from Reunion.
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
Biocorp will receive an initial milestone payment this year
Subscribe To Our Newsletter & Stay Updated